Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant
AI Sentiment
Highly Positive
9/10
as of 02-10-2026 1:08pm EST
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 26.6M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 48.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.72 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.10 - $15.91 | Next Earning Date: | 03-17-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -8467000.0 | FCF Growth: | N/A |
10% Owner
Avg Cost/Share
$4.50
Shares
258,367
Total Value
$1,162,651.50
Owned After
1,598,947
SEC Form 4
10% Owner
Avg Cost/Share
$4.50
Shares
734,747
Total Value
$3,306,361.50
Owned After
1,598,947
SEC Form 4
10% Owner
Avg Cost/Share
$4.50
Shares
741,272
Total Value
$3,335,724.00
Owned After
1,598,947
SEC Form 4
Avg Cost/Share
$8.71
Shares
433,332
Total Value
$3,774,321.72
Owned After
0
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| HiTron Systems Inc. | XCUR | 10% Owner | Jan 21, 2026 | Sell | $4.50 | 258,367 | $1,162,651.50 | 1,598,947 | |
| HiTron Systems Inc. | XCUR | 10% Owner | Jan 16, 2026 | Sell | $4.50 | 734,747 | $3,306,361.50 | 1,598,947 | |
| HiTron Systems Inc. | XCUR | 10% Owner | Jan 7, 2026 | Sell | $4.50 | 741,272 | $3,335,724.00 | 1,598,947 | |
| SANGSANGIN INVESTMENT & SECURITIES CO., LTD. | XCUR | 10% Owner | Dec 8, 2025 | Sell | $8.71 | 433,332 | $3,774,321.72 | 0 |
XCUR Breaking Stock News: Dive into XCUR Ticker-Specific Updates for Smart Investing
AI Sentiment
Highly Positive
9/10
See how XCUR stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "XCUR Exicure Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.